RE:RE:RE:We ran from 8-12,cents to $1 during the last run up. Ovechkin wrote:
If this market has taught me anything it can get parabolic really quick especially on a sales license over a cultivation license. IF, we can get our sales license within the next couple of month and release supply agreements for North Road Ventures watch out. I still think we are gunning for an export deal into Europe. Make total sense $2-$3 is in range short term IMO business model speaks for itself and can generate revenue in the short run. Not many companies with a SALES license under $2 a share. I can only think of Invictus MD. Also, I appreciate the correction on RKS investing @.40/share. Regardless, my point is that a capital corps job is to find undervalued stocks, buy-in then wait for a run-up to increase their book value. For instance RKS bought 500,000 shares of TGOD @50 cents. Small potatoes? Sure.. but a 250,000 investment now is 2 million dollars. Check out their portfolio of goods.. they clearly see something in Liberty which will bring them more book value. I STAND BY $2-$3
Almost fully agree expect now we have a few sales licensed companies trading under 2$ due to this market correction. I'll add THC and HVT to that list . There's also a few companies over 2$ with no sales license!! I'm pretty good at speculative valuations, and this will see 2$ IMO . All it takes is revenue and that's coming in the next year .